MX1
Basic information
Region (hg38): 21:41420020-41470071
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (89 variants)
- not_provided (8 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MX1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002462.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 85 | 89 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 85 | 6 | 3 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MX1 | protein_coding | protein_coding | ENST00000398600 | 13 | 38911 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.42e-18 | 0.0181 | 125576 | 2 | 170 | 125748 | 0.000684 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.319 | 375 | 393 | 0.955 | 0.0000232 | 4379 |
Missense in Polyphen | 109 | 136.21 | 0.80024 | 1400 | ||
Synonymous | 0.297 | 152 | 157 | 0.970 | 0.0000100 | 1257 |
Loss of Function | 0.587 | 29 | 32.6 | 0.889 | 0.00000156 | 385 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00400 | 0.00393 |
Ashkenazi Jewish | 0.00109 | 0.00109 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000564 | 0.000563 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000261 | 0.000229 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Interferon-induced dynamin-like GTPase with antiviral activity against a wide range of RNA viruses and some DNA viruses. Its target viruses include negative-stranded RNA viruses and HBV through binding and inactivation of their ribonucleocapsid. May also antagonize reoviridae and asfarviridae replication. Inhibits thogoto virus (THOV) replication by preventing the nuclear import of viral nucleocapsids. Inhibits La Crosse virus (LACV) replication by sequestering viral nucleoprotein in perinuclear complexes, preventing genome amplification, budding, and egress. Inhibits influenza A virus (IAV) replication by decreasing or delaying NP synthesis and by blocking endocytic traffic of incoming virus particles. Enhances ER stress-mediated cell death after influenza virus infection. May regulate the calcium channel activity of TRPCs. {ECO:0000269|PubMed:11880649, ECO:0000269|PubMed:14687945, ECO:0000269|PubMed:14752052, ECO:0000269|PubMed:15047845, ECO:0000269|PubMed:15355513, ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:16202617, ECO:0000269|PubMed:16413306, ECO:0000269|PubMed:17374778, ECO:0000269|PubMed:18668195, ECO:0000269|PubMed:19109387, ECO:0000269|PubMed:21900240, ECO:0000269|PubMed:21992152}.;
- Pathway
- Influenza A - Homo sapiens (human);Measles - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);The human immune response to tuberculosis;Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.498
Intolerance Scores
- loftool
- 0.224
- rvis_EVS
- -0.39
- rvis_percentile_EVS
- 27.05
Haploinsufficiency Scores
- pHI
- 0.170
- hipred
- N
- hipred_score
- 0.298
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.875
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mx2
- Phenotype
Gene ontology
- Biological process
- mitochondrial fission;dynamin family protein polymerization involved in mitochondrial fission;apoptotic process;defense response;signal transduction;response to virus;response to type I interferon;negative regulation of viral genome replication;innate immune response;defense response to virus;type I interferon signaling pathway;membrane fusion
- Cellular component
- nucleus;cytoplasm;endoplasmic reticulum membrane;cytosol;membrane;nuclear membrane;mitochondrial membrane;perinuclear region of cytoplasm
- Molecular function
- GTPase activity;protein binding;GTP binding;microtubule binding;identical protein binding